-+ 0.00%
-+ 0.00%
-+ 0.00%

PMGC unit NorthStrive Biosciences partners with Charles River to advance EL-22, EL-32 programs

PUBT·09/29/2026 11:33:53
Listen to the news
PMGC unit NorthStrive Biosciences partners with Charles River to advance EL-22, EL-32 programs
  • PMGC Holdings’ NorthStrive Biosciences signed a statement of work with Charles River Laboratories to support EL-22 and EL-32 development.
  • Charles River will run analytical testing to quantify plasmid copy number for NorthStrive’s engineered bacterial product candidates.
  • Data is intended to support product identity, manufacturing consistency, comparability, and NorthStrive’s push toward an IND-enabling framework.
  • Work supports NorthStrive’s engineered probiotic platform targeting muscle preservation, including in patients using GLP-1 weight-loss treatments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290733PRIMZONEFULLFEED9835694) on September 29, 2026, and is solely responsible for the information contained therein.